PT690856E - Compostos anti-tumor composicoes farmaceuticas metodos de preparacao dos mesmos e de tratamento - Google Patents

Compostos anti-tumor composicoes farmaceuticas metodos de preparacao dos mesmos e de tratamento

Info

Publication number
PT690856E
PT690856E PT94912300T PT94912300T PT690856E PT 690856 E PT690856 E PT 690856E PT 94912300 T PT94912300 T PT 94912300T PT 94912300 T PT94912300 T PT 94912300T PT 690856 E PT690856 E PT 690856E
Authority
PT
Portugal
Prior art keywords
treatment
pharmaceutical compositions
preparation
same
tumor compounds
Prior art date
Application number
PT94912300T
Other languages
English (en)
Portuguese (pt)
Inventor
Iwao Ojima
Ezio Bompardelli
Original Assignee
Res Found Of State Univ Of New
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Found Of State Univ Of New, Indena Spa filed Critical Res Found Of State Univ Of New
Publication of PT690856E publication Critical patent/PT690856E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT94912300T 1993-03-26 1994-03-24 Compostos anti-tumor composicoes farmaceuticas metodos de preparacao dos mesmos e de tratamento PT690856E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/040,189 US5475011A (en) 1993-03-26 1993-03-26 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment

Publications (1)

Publication Number Publication Date
PT690856E true PT690856E (pt) 2003-04-30

Family

ID=21909617

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94912300T PT690856E (pt) 1993-03-26 1994-03-24 Compostos anti-tumor composicoes farmaceuticas metodos de preparacao dos mesmos e de tratamento

Country Status (19)

Country Link
US (3) US5475011A (en:Method)
EP (1) EP0690856B1 (en:Method)
JP (2) JP3157165B2 (en:Method)
KR (1) KR100223720B1 (en:Method)
CN (1) CN1067682C (en:Method)
AT (1) ATE229018T1 (en:Method)
AU (1) AU676041B2 (en:Method)
CA (1) CA2158147C (en:Method)
CZ (1) CZ288924B6 (en:Method)
DE (1) DE69431833T2 (en:Method)
DK (1) DK0690856T3 (en:Method)
ES (1) ES2190440T3 (en:Method)
HU (1) HUT73848A (en:Method)
NO (1) NO311722B1 (en:Method)
PL (2) PL179587B1 (en:Method)
PT (1) PT690856E (en:Method)
RU (1) RU2137764C1 (en:Method)
SK (1) SK282317B6 (en:Method)
WO (1) WO1994022856A1 (en:Method)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335362B1 (en) * 1991-09-23 2002-01-01 Florida State University Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US6005120A (en) 1993-07-20 1999-12-21 Florida State University Tricyclic and tetracyclic taxanes
FR2718137B1 (fr) * 1994-04-05 1996-04-26 Rhone Poulenc Rorer Sa Procédé de préparation de trialcoylsilyl-7 baccatine III.
US5763477A (en) * 1994-07-22 1998-06-09 Dr. Reddy's Research Foundation Taxane derivatives from 14-β-hydroxy-10 deacetylbaccatin III
IT1275936B1 (it) * 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
BR9608040B1 (pt) 1995-04-28 2010-02-23 composto taxàide pentacÍclico.
IT1275435B (it) * 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono
EP0747372A1 (en) * 1995-06-06 1996-12-11 Dr. Reddy's Research Foundation Taxane derivatives from 14-beta-hydroxy-10 deacetybaccatin III
US5654448A (en) * 1995-10-02 1997-08-05 Xechem International, Inc. Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
US5840748A (en) * 1995-10-02 1998-11-24 Xechem International, Inc. Dihalocephalomannine and methods of use therefor
US5807888A (en) * 1995-12-13 1998-09-15 Xechem International, Inc. Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
US6177456B1 (en) 1995-10-02 2001-01-23 Xechem International, Inc. Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor
US5854278A (en) * 1995-12-13 1998-12-29 Xechem International, Inc. Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis
KR20040097250A (ko) 1996-05-24 2004-11-17 유니버시티 오브 브리티시 콜롬비아 신체 통로의 질병을 치료 또는 예방하기 위한 조성물 및방법
AU3572397A (en) * 1996-07-02 1998-01-21 Bristol-Myers Squibb Company Ortho-ester analogs of paclitaxel
KR100225535B1 (ko) * 1996-08-27 1999-10-15 정지석 파클리탁셀의 제조방법
EP0868422A1 (de) * 1996-09-24 1998-10-07 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US5811452A (en) * 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
DK1019347T3 (da) 1997-08-21 2003-07-21 Univ Florida State Fremgangsmåde til syntesen af taxaner
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
ITMI991483A1 (it) * 1999-07-06 2001-01-06 Indena Spa Derivati tassanici e procedimenti per la loro preparazione
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CA2386772C (en) * 1999-10-15 2009-01-13 Daiichi Pharmaceutical Co., Ltd. Pentacyclic taxane compound
EP1242401B1 (en) * 1999-11-24 2006-12-27 Immunogen, Inc. Cytotoxic agents comprising taxanes and their therapeutic use
HUP0200756A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C7 carbonate substituted taxanes as antitumor agents and pharmaceutical compositions containing them
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
EP1165550A1 (en) 2000-02-02 2002-01-02 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes as antitumor agents
JP2003522172A (ja) * 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ１０エステル置換タキサン
US6916942B2 (en) * 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
IT1318678B1 (it) * 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
US6449899B1 (en) * 2001-03-08 2002-09-17 Council Of Scientific And Industrial Research Method for inducing improved seed germination in Podophyllum hexandrum Royle
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20012186A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
TWI333856B (en) * 2001-11-29 2010-12-01 Daiichi Seiyaku Co Crystals of taxane and process for their production
US7390898B2 (en) * 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
BR0313197A (pt) 2002-08-02 2005-08-09 Immunogen Inc Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
ITMI20021921A1 (it) 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
CA2501805C (en) * 2002-10-09 2012-05-22 Phytogen Life Sciences, Inc. Novel taxanes and methods related to use and preparation thereof
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
TW200533339A (en) * 2004-03-16 2005-10-16 Bristol Myers Squibb Co Therapeutic synergy of anti-cancer compounds
AU2004224925C1 (en) * 2004-08-30 2011-07-21 Biotest Ag Immunoconjugates targeting syndecan-1 expressing cells and use thereof
US7446126B2 (en) * 2004-10-08 2008-11-04 Indena S.P.A. Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
MX2007009748A (es) * 2005-02-14 2007-09-26 Univ Florida State Res Found Composiciones de taxano sustituidas con esteres ciclopropilicos en c10.
EP2428510A3 (en) * 2005-03-31 2012-06-13 Accord Healthcare Inc. Preparation of taxanes from 9-dihydro-13-acetylbaccatin III
US8207358B2 (en) * 2005-11-04 2012-06-26 Accord Healthcare Ltd. Methods for the preparation of taxanes using chiral auxiliaries
CN100516067C (zh) * 2006-01-10 2009-07-22 上海恒瑞医药有限公司 具有抗肿瘤活性的紫杉酚衍生物
US7615653B2 (en) * 2006-03-15 2009-11-10 The Research Foundation Of State University Of New York Anti-tuberculosis taxane compounds
US20100137221A1 (en) * 2007-02-27 2010-06-03 University Utah Research Foundation Peptides that interact with topoisomerase i and methods thereof
RU2370261C2 (ru) * 2007-08-03 2009-10-20 Закрытое Акционерное Общество "Биокад" Стабильная эмульсия для парентерального введения плохо растворимых в воде соединений, обладающих противоопухолевой активностью, и способ ее получения
ES2526433T3 (es) * 2007-12-26 2015-01-12 Biotest Ag Inmunoconjugados dirigidos a CD138 y usos de los mismos
JP2011507933A (ja) * 2007-12-26 2011-03-10 バイオテスト・アクチエンゲゼルシヤフト 免疫複合体の細胞傷害性副作用の低減及び有効性の改善方法
AR069981A1 (es) * 2007-12-26 2010-03-03 Biotest Ag Los "anticuerpo modificado geneticamente que reconocen cd138".
AU2008339913B2 (en) * 2007-12-26 2014-03-20 Biotest Ag Methods and agents for improving targeting of CD138 expressing tumor cells
DK2080764T3 (da) 2008-01-18 2012-09-24 Indena Spa Faste former af ortataxel
EP2080763A1 (en) * 2008-01-18 2009-07-22 INDENA S.p.A. Crystalline form I of ortataxel
US8242166B2 (en) * 2008-03-31 2012-08-14 Florida State University Research Foundation, Inc. C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes
KR101764927B1 (ko) 2008-04-30 2017-08-03 이뮤노젠 아이엔씨 가교제 및 그 용도
US8790691B2 (en) 2008-05-23 2014-07-29 The University Of British Columbia Modified drugs for use in liposomal nanoparticles
CN101838281B (zh) * 2010-05-20 2015-02-18 上海博速医药科技有限公司 一种多西他赛手性侧链中间体的制备方法
JP5605511B2 (ja) 2011-08-02 2014-10-15 アステラス製薬株式会社 薬剤の併用による癌治療方法
KR20140100571A (ko) 2011-12-08 2014-08-14 바이오테스트 아게 Ｃｄ１３８을 타겟팅하는 면역접합체의 용도
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
JP6100627B2 (ja) * 2013-06-24 2017-03-22 株式会社パイロットコーポレーション 熱消色性筆記具インキ組成物及びそれを内蔵した筆記具
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物
CN106414465B (zh) 2014-02-28 2021-11-16 杭州多禧生物科技有限公司 带电荷链接体及其在共轭反应上的应用
US9557445B2 (en) 2015-02-24 2017-01-31 Arkema France Optical diffusion blend materials for LED lighting
EP4678240A2 (en) 2015-07-12 2026-01-14 Hangzhou Dac Biotech Co., Ltd. Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220150408A (ko) 2016-11-14 2022-11-10 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
AU2019223076A1 (en) 2018-02-21 2020-10-08 Celgene Corporation BCMA-binding antibodies and uses thereof
CN109485593A (zh) * 2018-12-12 2019-03-19 福建紫杉园生物有限公司 一种拉洛他赛手性侧链的合成工艺
JP2024541058A (ja) 2021-11-03 2024-11-06 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． 抗体の特異的共役

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876399A (en) * 1987-11-02 1989-10-24 Research Corporation Technologies, Inc. Taxols, their preparation and intermediates thereof
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US4857683A (en) * 1988-12-28 1989-08-15 W. H. Brady Co. Membrane switchcores with key cell contact elements connected together for continuous path testing
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
US5015722A (en) * 1990-04-04 1991-05-14 Hoechst Celanese Corporation Melt-processable polyester capable of forming an anisotropic melt which exhibits a highly attractive balance between its molding and heat deflection temperatures
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
FR2698363B1 (fr) * 1992-11-23 1994-12-30 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment

Also Published As

Publication number Publication date
NO953796D0 (no) 1995-09-25
SK282317B6 (sk) 2002-01-07
US5599820A (en) 1997-02-04
NO953796L (no) 1995-11-15
JPH08508497A (ja) 1996-09-10
EP0690856A1 (en) 1996-01-10
PL180708B1 (pl) 2001-03-30
PL310827A1 (en) 1996-01-08
CZ248095A3 (en) 1996-03-13
WO1994022856A1 (en) 1994-10-13
JP3157165B2 (ja) 2001-04-16
SK118395A3 (en) 1996-06-05
CN1067682C (zh) 2001-06-27
KR100223720B1 (ko) 1999-10-15
NO311722B1 (no) 2002-01-14
AU6491694A (en) 1994-10-24
HUT73848A (en) 1996-09-30
CA2158147A1 (en) 1994-10-13
US5705508A (en) 1998-01-06
EP0690856B1 (en) 2002-12-04
HU9502642D0 (en) 1995-11-28
CN1123547A (zh) 1996-05-29
CZ288924B6 (cs) 2001-09-12
KR960701045A (ko) 1996-02-24
JP3145993B2 (ja) 2001-03-12
DE69431833T2 (de) 2003-11-06
DK0690856T3 (da) 2003-03-31
RU2137764C1 (ru) 1999-09-20
ES2190440T3 (es) 2003-08-01
ATE229018T1 (de) 2002-12-15
JPH11322737A (ja) 1999-11-24
EP0690856A4 (en:Method) 1996-02-07
PL179587B1 (pl) 2000-09-29
AU676041B2 (en) 1997-02-27
US5475011A (en) 1995-12-12
CA2158147C (en) 1999-10-05
DE69431833D1 (de) 2003-01-16

Similar Documents

Publication Publication Date Title
PT690856E (pt) Compostos anti-tumor composicoes farmaceuticas metodos de preparacao dos mesmos e de tratamento
FI921030A0 (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
DE69520880D1 (de) 9-deoxotaxan verbindungen
YU89791A (sh) Postupak za dobijanje enantioselektivnih derivata fenilizoserina
RU95114377A (ru) 7-гало- и 7бета, 8бета -метано-таксолы, фармацевтическая композиция, промежуточные соединения, способы получения промежуточных соединений
RU2000128058A (ru) Эктеинасцидины, фармацевтическая композиция, содержащая их и способ лечения опухолей
ES2103479T3 (es) Derivados de anilida.
HUP0203425A2 (en) Quinazoline derivatives, process for their preparation and their use
HUP9701158A1 (hu) Biciklusos kondenzált piridinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
MX9302214A (es) Derivados de taxol y proceso para su preparacion
FI954898A0 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
HUP9802487A2 (hu) Intermedierek félszintetikus taxánokhoz és eljárás előállításukra
YU89691A (sh) Postupak za dobijanje stereoselektivnih derivata fenilizoserina
AU5425794A (en) Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same
SE9904129D0 (sv) Novel compounds
EA200000847A1 (ru) Противоопухолевые средства
EA200000431A3 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
TW359671B (en) Novel methods for the preparation of taxanes using oxazolidine intermediates
ES554901A0 (es) Un procedimiento para preparar derivados de oxotiazolidina
CY1106396T1 (el) Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν
UY25807A1 (es) Caprolactamas sustituidas, composiciones farmacéuticas que las contienen, y su uso en el tratamiento de tumores.
PT98976A (pt) Processo para a preparacao de heteroarilmetilbenzenos
DE69724472D1 (de) Selenophen-antitumormittel
MD1738F2 (ro) Sare de diclavulanat, procedeu de obţinere şi compoziţie farmaceutică pe baza ei
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma